Omkar Speciality Chemicals surged almost 2 percent on Wednesday on the news that company received a process patent for a chemical used in pharma industry.
Pravin Herlekar, Chairman and Managing Director of the company told CNBC-TV18 that the patent, fourth one for the firm, is for beta ketoester chemical. There are seven more patents in the pipeline, he added.
Omkar Speciality Chemicals will be manufacturing beta ketoestar from the company’s existing facility, he said.Watch video for more...
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
